References
- Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
- Garand R, Duchayne E, Blanchard D, Robillard N, Kuhlein E, Fenneteau O, et al. Minimally differentiated erythroleukaemia (AML M6 ‘variant’): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1995; 90: 868–875
- Cheson B D, Cassileth P A, Head D R, Schiffer C A, Bennett J M, Bloomfield C D, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–819
- Cheson B D, Bennett J M, Kopecky K J, Buchner T, Willman C L, Estey E H, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 21: 4642–4649
- Wells A W, Bown N, Reid M M, Hamilton P J, Jackson G H, Taylor P R. Erythroleukaemia in the north of England: a population based study. J Clin Pathol 2001; 54: 608–612
- Bruning R D, Bennett J, Matutes E, Head D, Flandrin G, Harris N L, . Acute myeloid leukaemia not otherwise categorised. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman, et al. IARC Press, Lyon 2001; 97–99
- Appelbaum F R, Rowe J M, Radich J, Dick J E. Acute myeloid leukemia. Hematol Am Soc Hematol Educ Program 2001; 00: 62–86
- Kowal-Vern A, Mazzella F M, Cotelingam J D, Shrit M A, Rector J T, Schumacher H R. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. Am J Hematol 2000; 65: 5–13
- Mazzella F M, Schumacher H R. Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J Clin Pathol 2002; 55: 800
- Park S, Picard F, Azgui Z, Viguie F, Merlat A, Guesnu M, et al. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification. Leuk Res 2002; 26: 423–429
- Colita A, Belhabri A, Chelghoum Y, Charrin C, Fiere D, Thomas X. Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases. Ann Oncol 2001; 12: 451–455
- Killick S, Matutes E, Powles R L, Min T, Treleaven J G, Rege K P, et al. Acute erythroid leukemia (M6): outcome of bone marrow transplantation. Leuk Lymphoma 1999; 35: 99–107
- Mazzella F M, Kowal-Vern A, Shrit M A, Wibowo A L, Rector J T, Cotelingam J D, et al. Acute erythroleukemia: evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis. Am J Clin Pathol 1998; 110: 590–598
- Park S, Picard F, Guesnu M, Maloum K, Leblond V, Dreyfus F. Erythroleukaemia and RAEB-t: a same disease. Leukemia 2004; 18: 888–890
- Davey F R, Abraham N, Jr, Brunetto V L, MacCallum J M, Nelson D A, Ball E D, et al. Morphologic characteristics of erythroleukemia (acute myeloid leukemia;FAB-M6): a CALGB study. Am J Hematol 1995; 49: 29–38
- Park S, Picard F, Dreyfus F. Erythroleukemia: a need for a new definition. Leukemia 2002; 16: 1399–1401